Ballicules.com

Dronabinol

MARINOL

What it isSynthetic delta-9-THC and CB1 agonist; chemotherapy nausea and appetite stimulation in AIDS.

Why this oneIt provides a measured single-cannabinoid product rather than the variable mixture delivered by inhaled cannabis.

What limits itDysphoria, dizziness, and tachycardia are worst in older adults; oral absorption is slow and variable, and it is Schedule III.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Anorexia with weight loss in AIDSAdults2.5 mg BID2.5–5 mg BID10 mg BID
Chemotherapy-induced nausea/vomiting (refractory)Adults5 mg/m² pre-chemo, then q2–4h5 mg/m² q2–4h4–6 doses/day

Titration AIDS anorexia: increase gradually (e.g., 2.5 mg AM / 5 mg PM, then 5 mg BID) as tolerated.

Renal Undefined

Hepatic Undefined

CINV: repeat every 2–4 h after chemotherapy, 4–6 doses per day.

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy May cause fetal harm; avoid use in pregnancy

Lactation HIV-infected women advised not to breastfeed (HIV transmission); monitor infant weight where breastfeeding appropriate

NO BOXED WARNINGS

Principal riskDysphoria and dizziness, worst in the elderly

Cost, est. cash$10–$300/month

Generic entry2008

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability2 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryC

Defining liabilitySedation, QT prolongation, extrapyramidal symptoms or anticholinergic toxicity vary by receptor target.

Mechanism of action: Dronabinol ballicule

Dronabinol ballicule: receptor binding, kinetics and half-life diagram

Open Dronabinol in the interactive console ↗

Memory aids: mascots and interaction avatars

Dronabinol MARINOL mascot mnemonic cartoon
“Marijuana Drone”
Dronabinol CYP2C9 substrate avatar
CYP2C9 substrate
Dronabinol CYP3A4 substrate avatar
CYP3A4 substrate

Open Dronabinol in the interactive console ↗